Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma: A Retrospective Registry-Based Study Using the Korean Organ Transplant Registry (KOTRY)

Sang-Hoon Kim; Shin Hwang; Bong-Wan Kim; Dong Jin Joo; Kwang-Woong Lee; Gyu-Seong Choi; Je Ho Ryu; Dong-Sik Kim; Dongho Choi; Jai Young Cho; Young Kyoung You; Dongho Choi; Tae-Seok Kim; PyoungJae Park

doi:10.12659/AOT.949241

16 December 2025 : Original article

Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma: A Retrospective Registry-Based Study Using the Korean Organ Transplant Registry (KOTRY)

Sang-Hoon Kim^{BCDEF 1}, Shin Hwang^{ABG 1*}, Bong-Wan Kim^{ABG 2}, Dong Jin Joo^{ABD 3}, Kwang-Woong Lee^{ABD 4}, Gyu-Seong Choi^{AD 5}, Je Ho Ryu^{ABD 6}, Dong-Sik Kim^{ABD 7}, Dongho Choi^{ABD 8}, Jai Young Cho^{ABD 9}, Young Kyoung You^{ABD 10}, Dongho Choi^{ABD 11}, Tae-Seok Kim^{ABD 12}, PyoungJae Park^{ABD 13}

DOI: 10.12659/AOT.949241

Ann Transplant 2025; 30:e949241

Authors information Article notes Copyright and License information

Introduction Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Figure 6 Kaplan-Meier survival curves according to postoperative administration of everolimus. (A) Overall survival (OS) and (B) recurrence-free survival (RFS) by everolimus use within 1 month after liver transplantation (LT). (C) OS and (D) RFS within 6 months.

Back to the Article

Liver Transplantation for Combined Hepatocellular-Cholangiocarcinoma: A Retrospective Registry-Based Study Using the Korean Organ Transplant Registry (KOTRY)

Your Privacy